Home › All Companies › AMIX

Autonomix Medical, Inc. (AMIX)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-02-11

Key Insights

  • The company has a significant amount of convertible debt and warrants outstanding, which could lead to significant dilution if converted or exercised.
  • The company has raised additional capital through an ATM program and a purchase agreement, indicating the need for additional financing to fund operations.
  • The company's net loss and negative cash flows from operations suggest ongoing challenges with profitability and liquidity.
Sentiment: Negative Significance: 7/10
View Original Filing →
Current Report Filed: 2026-01-16

Key Insights

  • Autonomix Medical, Inc. has received a deficiency letter from Nasdaq notifying the company that its common stock has closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market.
  • The company has been provided an initial period of 180 calendar days, or until July 13, 2026, to regain compliance with the minimum bid price rule. If the company is unable to regain compliance by the deadline, it may be afforded a second 180-day compliance period.
  • The company intends to monitor the closing bid price of its common stock and may consider options to regain compliance, such as a reverse stock split, but there is no assurance it will be able to do so.
Sentiment: Negative Significance: 6/10
View Original Filing →
Current Report Filed: 2026-01-09

Key Insights

  • Autonomix Medical presented new positive subgroup data from its PoC study on pain relief in pancreatic cancer patients across all disease stages, suggesting a potential significant therapeutic benefit.
  • The company posted an updated corporate presentation, providing investors with the latest developments and financial information.
  • As an emerging growth company, Autonomix Medical has the flexibility to comply with new or revised financial accounting standards, which could impact its future financial reporting.
Sentiment: Positive Significance: 7/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.